Huang, J., Xiao, J., Fang, W., Lu, P., Fan, Q., Shu, Y., … He, J. (2021). Anlotinib for previously treated advanced or metastatic esophageal squamous cell carcinoma: A double-blind randomized phase 2 trial. Cancer Medicine, 10(5), 1681-1689. https://doi.org/10.1002/cam4.3771